Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Sees Large Growth in Short Interest

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 6,900 shares, a growth of 146.4% from the November 15th total of 2,800 shares. Based on an average daily trading volume, of 6,100 shares, the days-to-cover ratio is currently 1.1 days.

Clinuvel Pharmaceuticals Price Performance

OTCMKTS CLVLY traded up $0.18 during trading on Wednesday, hitting $8.30. 5,823 shares of the company traded hands, compared to its average volume of 2,847. The business has a fifty day simple moving average of $9.07 and a 200 day simple moving average of $9.56. Clinuvel Pharmaceuticals has a 12 month low of $8.00 and a 12 month high of $11.71.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).